Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
The companies aim to expand treatment options for millions living with metabolic disorders
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Captured microbes are then neutralized on engineered microbicidal surfaces
Growing patent filings and tier-2 innovators reflect expanding national research base
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
Angelini Ventures has already invested €125 million in 22 startups
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
Subscribe To Our Newsletter & Stay Updated
